Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that rapid identification, isolation, and strict infection control are crucial to manage SARS outbreaks.

Covid-19 can cause skin and oral symptoms, like taste changes, which help in detection and management.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Cedrol may help reduce liver fat and fat cell growth caused by corticosteroids.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Men have more severe COVID-19 outcomes than women.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Men have higher COVID-19 mortality rates than women due to biological and lifestyle factors.

Higher ACE2 levels in certain tissues may worsen COVID-19 in people with other health issues, especially older adults.

Targeting ACE2 and TMPRSS2 may help prevent or treat COVID-19 in cancer patients.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

Different ACE2 gene versions may affect COVID-19 impact based on age and suggest some hair loss drugs could be potential treatments.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Mineralocorticoid receptor antagonist therapy does not significantly reduce mortality in COVID-19 patients.

Genetic differences affect COVID-19 severity and treatment effectiveness.

Young women in West Bengal, India, with PCOS often have estrogen resistance, leptin receptor issues, folate deficiency, T2DM, and acanthosis, commonly linked to obesity.

Many COVID-19 patients have long-term symptoms, especially women, but certain medications may help reduce these symptoms.

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.